Physician profile
Bryant Lee
NPI 1437154960
$1,502.57
in general payments reported to CMS, 2019-2025
10 companies · $1,173 in 2025
The $1,173 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.66 · 2021: $14.98 · 2022: $23.09 · 2023: $199 · 2024: $42.35 · 2025: $1,173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004 · Travel and Lodging: $393 · Education: $17.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.62 |
| Travel and Lodging | $392.51 |
| Education | $17.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $551.35 | 2025 | |
| Optinose US, INC. | $369.75 | 2019-2025 | |
| Glaxosmithkline, LLC. | $175.04 | 2021-2025 | Nucala |
| Genzyme Corporation | $174.05 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $98.72 | 2023-2025 | Dupixent |
| Grifols USA, LLC | $42.85 | 2025 | Xembify |
| Phathom Pharmaceuticals, INC. | $25.09 | 2025 | Voquezna |
| Csl Behring | $23.94 | 2025 | Hizentra |
| Abbvie INC. | $23.09 | 2022 | |
| Mimedx Group, INC. | $18.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryant Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.